Global Covid-19 Vaccine Competitive Landscape Professional Research Report 2025
Description
Global Covid-19 Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
COVID-19 vaccines are medical products developed to provide immunity against the SARS-CoV-2 virus, which causes COVID-19. These vaccines aim to trigger an immune response in the body without causing the disease itself. They contain a weakened or inactivated form of the virus, specific viral proteins, or genetic material that instructs the body＇s cells to produce viral proteins. Once administered, the immune system recognizes these viral components as foreign and mounts an immune response by producing antibodies and memory cells. In the event of a future infection, the immune system can quickly recognize and neutralize the virus, preventing severe illness and reducing the risk of transmission to others. COVID-19 vaccines have been a critical tool in combating the pandemic and are deployed through mass vaccination campaigns worldwide. Rigorous testing and regulatory approval processes ensure their safety and efficacy, and ongoing research and monitoring continue to provide valuable data on vaccine effectiveness, duration of immunity, and potential variants. Vaccination, along with other preventive measures, such as mask-wearing and social distancing, plays a crucial role in controlling the spread of COVID-19 and bringing an end to the global health crisis.
According to DIResearch's in-depth investigation and research, the global Covid-19 Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Covid-19 Vaccine include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics, Sanofi etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Covid-19 Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Covid-19 Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Covid-19 Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Covid-19 Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Covid-19 Vaccine Include:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Covid-19 Vaccine Product Segment Include:
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Covid-19 Vaccine Product Application Include:
Adults
Children
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Covid-19 Vaccine Industry PESTEL Analysis
Chapter 3: Global Covid-19 Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Covid-19 Vaccine Major Regional Market Size and Forecast Analysis
Chapter 5: Global Covid-19 Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Covid-19 Vaccine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Covid-19 Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Covid-19 Vaccine Product by Type
- 1.2.1 DNA
- 1.2.2 Non-replicating Viral Vector
- 1.2.3 Protein Subunit
- 1.2.4 RNA
- 1.2.5 Others
- 1.3 Covid-19 Vaccine Product by Application
- 1.3.1 Adults
- 1.3.2 Children
- 1.4 Global Covid-19 Vaccine Market Size Analysis (2020-2032)
- 1.5 Covid-19 Vaccine Market Development Status and Trends
- 1.5.1 Covid-19 Vaccine Industry Development Status Analysis
- 1.5.2 Covid-19 Vaccine Industry Development Trends Analysis
- 2 Covid-19 Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Covid-19 Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Covid-19 Vaccine Market Analysis by Regions
- 4.1 Covid-19 Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Covid-19 Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Covid-19 Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Covid-19 Vaccine Revenue Forecast by Region (2026-2032)
- 5 Global Covid-19 Vaccine Market Size by Type and Application
- 5.1 Global Covid-19 Vaccine Market Size by Type (2020-2032)
- 5.2 Global Covid-19 Vaccine Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Covid-19 Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Covid-19 Vaccine Market Size by Type
- 6.4 North America Covid-19 Vaccine Market Size by Application
- 6.5 North America Covid-19 Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Covid-19 Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Covid-19 Vaccine Market Size by Type
- 7.4 Europe Covid-19 Vaccine Market Size by Application
- 7.5 Europe Covid-19 Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Covid-19 Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Covid-19 Vaccine Market Size by Type
- 8.4 China Covid-19 Vaccine Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Covid-19 Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Covid-19 Vaccine Market Size by Type
- 9.4 APAC (excl. China) Covid-19 Vaccine Market Size by Application
- 9.5 APAC (excl. China) Covid-19 Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Covid-19 Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Covid-19 Vaccine Market Size by Type
- 10.4 Latin America Covid-19 Vaccine Market Size by Application
- 10.5 Latin America Covid-19 Vaccine Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Covid-19 Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Covid-19 Vaccine Market Size by Type
- 11.4 Middle East & Africa Covid-19 Vaccine Market Size by Application
- 11.5 Middle East & Africa Covid-19 Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Covid-19 Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Covid-19 Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Covid-19 Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Moderna
- 13.1.1 Moderna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Moderna Covid-19 Vaccine Product Portfolio
- 13.1.3 Moderna Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CanSino Biologicals
- 13.2.1 CanSino Biologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CanSino Biologicals Covid-19 Vaccine Product Portfolio
- 13.2.3 CanSino Biologicals Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Inovio Pharmaceuticals
- 13.3.1 Inovio Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Inovio Pharmaceuticals Covid-19 Vaccine Product Portfolio
- 13.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Shenzhen Geno-Immune Medical Institute
- 13.4.1 Shenzhen Geno-Immune Medical Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product Portfolio
- 13.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 GlaxoSmithKine
- 13.5.1 GlaxoSmithKine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 GlaxoSmithKine Covid-19 Vaccine Product Portfolio
- 13.5.3 GlaxoSmithKine Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Pfizer
- 13.6.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Pfizer Covid-19 Vaccine Product Portfolio
- 13.6.3 Pfizer Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Johnson＆Johnson
- 13.7.1 Johnson＆Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Johnson＆Johnson Covid-19 Vaccine Product Portfolio
- 13.7.3 Johnson＆Johnson Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Heat Biologics
- 13.8.1 Heat Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Heat Biologics Covid-19 Vaccine Product Portfolio
- 13.8.3 Heat Biologics Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Sanofi
- 13.9.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Sanofi Covid-19 Vaccine Product Portfolio
- 13.9.3 Sanofi Covid-19 Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Covid-19 Vaccine Industry Chain Analysis
- 14.2 Covid-19 Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Covid-19 Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Covid-19 Vaccine Typical Downstream Customers
- 14.4 Covid-19 Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
